Oscar Health, Inc., a prominent health insurance company based in New York, has been making significant strides in the healthcare sector. As of March 19, 2026, the company’s stock closed at $12.63 on the New York Stock Exchange. Despite a challenging year, Oscar Health’s market capitalization stands at $3.96 billion, reflecting its substantial presence in the financials sector.
The company’s stock has experienced notable fluctuations over the past year, reaching a 52-week high of $23.8 on October 6, 2025, and a low of $11.2 on April 20, 2025. These variations highlight the dynamic nature of the market and the company’s resilience in navigating these changes.
Oscar Health’s mission is to transform the healthcare industry through its innovative technology platform. By leveraging personalized data, the company aims to provide real-time, actionable insights and recommendations to its members. This includes guiding them to the most suitable doctors and hospitals, thereby enhancing the overall healthcare experience.
However, the company’s financial metrics indicate some challenges. The price-to-earnings ratio stands at -7.14, suggesting that the company is currently not generating profits. This negative ratio may be attributed to the company’s significant investments in technology and infrastructure aimed at achieving its long-term goals.
Despite these financial hurdles, Oscar Health remains committed to its vision of revolutionizing healthcare. The company’s focus on data-driven insights and personalized recommendations positions it as a forward-thinking player in the industry, poised to make a lasting impact on how healthcare services are delivered and experienced in the United States.
